<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.14003.004</object-id><label>Table 1.</label><caption><p>Comparison of antimicrobial susceptibility by <italic>Salmonella</italic> Typhi lineage.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.14003.004">http://dx.doi.org/10.7554/eLife.14003.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">E test</th><th colspan="3">Non-H58 (N=13)</th><th colspan="3">H58 (N=65)</th><th>p value*</th></tr><tr><th>MIC50</th><th>MIC90</th><th>GM (range)</th><th>MIC50</th><th>MIC90</th><th>GM (range)</th><th/></tr></thead><tbody><tr><td>Amoxicillin</td><td>0.5</td><td>1</td><td>0.77 (0.38&#8211;38)</td><td>0.75</td><td>&gt;256</td><td>1.43 (0.38&#8211;&gt;256)</td><td>0.0412</td></tr><tr><td>Chloramphenicol</td><td>3</td><td>4</td><td>2.7 (1.5&#8211;8)</td><td>4</td><td>12</td><td>5.7 (2&#8211;&gt;256)</td><td>0.0147</td></tr><tr><td>Ceftriaxone</td><td>0.06</td><td>0.06</td><td>0.06 (0.05&#8211;0.13)</td><td>0.09</td><td>0.19</td><td>0.11 (0.03&#8211;0.64)</td><td>0.0004</td></tr><tr><td>Gatifloxacin</td><td>0.13</td><td>0.25</td><td>0.06 (0.01&#8211;2)</td><td>0.13</td><td>2</td><td>0.21 (0.01&#8211;3)</td><td>0.1197</td></tr><tr><td>Nalidixic acid</td><td>&gt;256</td><td>&gt;256</td><td>21.6 (1&#8211;&gt;256)</td><td>&gt;256</td><td>&gt;256</td><td>346.8 (1&#8211;&gt;256)</td><td>0.0004</td></tr><tr><td>Ofloxacin</td><td>0.25</td><td>0.75</td><td>0.24 (0.03&#8211;&gt;32)</td><td>0.5</td><td>&gt;3232</td><td>1.09 (0.03&#8211;&gt;32)</td><td>0.0240</td></tr><tr><td>Trimethoprim sulphate</td><td>0.02</td><td>0.05</td><td>0.03 (0.02&#8211;0.05)</td><td>0.05</td><td>0.32</td><td>0.09 (0.01&#8211;&gt;32)</td><td>0.0016</td></tr><tr><td>Ciprofloxacin</td><td>0.13</td><td>0.75</td><td>0.11 (0.01&#8211;&gt;32)</td><td>0.38</td><td>&gt;32</td><td>0.80 (0.02&#8211;&gt;32)</td><td>0.0051</td></tr><tr><td>Ciprofloxacin susceptibility group</td><td colspan="3"/><td colspan="3"/><td>0.0008<sup>#</sup></td></tr><tr><td>- Susceptible</td><td colspan="3">6 (46.2%)</td><td colspan="3">4 (6.2%)</td><td/></tr><tr><td>- Intermediate</td><td colspan="3">4 (30.8%)</td><td colspan="3">48 (73.8%)</td><td/></tr><tr><td>- Resistant</td><td colspan="3">3 (23.1%)</td><td colspan="3">13 (20.0%)</td><td/></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*Comparisons between <italic>Salmonella</italic> Typhi lineage for MICs and ciprofloxacin susceptibility groups were based on the Wilcoxon rank sum test and Fisher&#8217;s exact test. respectively.</p></fn><fn id="tblfn2"><p>MIC: minimum inhibitory concentration, measured in &#181;g/ml</p></fn><fn id="tblfn3"><p>#p value for comparison of susceptible vs. intermediate/resistant combined between groups by Fisher&#8217;s exact test is 0.001.</p></fn><fn id="tblfn4"><p>GM: geometric mean, the upper range of the values was determined by multiplying the MIC by 2 if the result was &gt;X (for example, &gt;256 = 256*2 = 512).</p></fn></table-wrap-foot></table-wrap>